DK0817615T3 - Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal - Google Patents

Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal

Info

Publication number
DK0817615T3
DK0817615T3 DK96906784T DK96906784T DK0817615T3 DK 0817615 T3 DK0817615 T3 DK 0817615T3 DK 96906784 T DK96906784 T DK 96906784T DK 96906784 T DK96906784 T DK 96906784T DK 0817615 T3 DK0817615 T3 DK 0817615T3
Authority
DK
Denmark
Prior art keywords
composition
drug
pct
gastrointestinal tract
controlled release
Prior art date
Application number
DK96906784T
Other languages
English (en)
Inventor
Martti Marvola
Esko Marttila
Reija Yrjoelae
Esa Lahdenpaeae
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of DK0817615T3 publication Critical patent/DK0817615T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96906784T 1995-03-21 1996-03-20 Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal DK0817615T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI951316A FI98343C (fi) 1995-03-21 1995-03-21 Peroraalinen formulaatio
PCT/FI1996/000164 WO1996029058A1 (en) 1995-03-21 1996-03-20 Peroral composition for controlled release in the lower gastrointestinal tract

Publications (1)

Publication Number Publication Date
DK0817615T3 true DK0817615T3 (da) 2002-11-25

Family

ID=8543092

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906784T DK0817615T3 (da) 1995-03-21 1996-03-20 Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal

Country Status (16)

Country Link
US (1) US5962024A (da)
EP (1) EP0817615B1 (da)
JP (1) JPH11502217A (da)
AT (1) ATE221771T1 (da)
AU (1) AU694849B2 (da)
CA (1) CA2213747A1 (da)
DE (1) DE69622850T2 (da)
DK (1) DK0817615T3 (da)
ES (1) ES2181874T3 (da)
FI (1) FI98343C (da)
IL (1) IL117582A (da)
NO (1) NO312705B1 (da)
NZ (1) NZ303683A (da)
PT (1) PT817615E (da)
WO (1) WO1996029058A1 (da)
ZA (1) ZA962271B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
TW200500071A (en) * 2002-08-29 2005-01-01 Activbiotics Inc Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
US20050025829A1 (en) * 2003-07-29 2005-02-03 Kim Cherng-Ju Controlled drug release tablets
EP2210605B1 (en) * 2003-11-04 2017-03-01 TCD Royalty Sub, LLC Once daily dosage forms of trospium
CA2536401C (en) 2003-11-04 2011-08-30 Shire Laboratories Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
EP1830886B1 (en) 2004-12-27 2016-04-13 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US10071060B2 (en) * 2005-07-08 2018-09-11 Bioventures, Llc Asymmetrically coated table
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US7713549B2 (en) * 2006-06-30 2010-05-11 Board Of Trustees Of The University Of Arkansas Extended release perforated tablet
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
EP2334178A4 (en) 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
WO2010061846A1 (ja) * 2008-11-25 2010-06-03 田辺三菱製薬株式会社 口腔内速崩壊性錠及びその製造方法
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
JP6464142B2 (ja) 2013-03-14 2019-02-06 セラバイオーム，エルエルシー プロバイオティクス生物及び／又は治療剤の標的化胃腸管デリバリー
US20200253945A1 (en) * 2017-10-25 2020-08-13 Chiesi Farmaceutici S.P.A. Delayed release deferiprone tablets and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
PT93637A (pt) * 1989-04-20 1990-11-20 Procter & Gamble Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
JPH0334928A (ja) * 1989-06-29 1991-02-14 Teikoku Seiyaku Kk 潰瘍性大腸炎およびクローン病治療用経口投与製剤
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
WO1992016214A1 (en) * 1991-03-15 1992-10-01 Norwich Eaton Pharmaceuticals Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning

Also Published As

Publication number Publication date
IL117582A0 (en) 1996-07-23
NZ303683A (en) 1998-07-28
WO1996029058A1 (en) 1996-09-26
JPH11502217A (ja) 1999-02-23
DE69622850T2 (de) 2003-04-24
US5962024A (en) 1999-10-05
ATE221771T1 (de) 2002-08-15
IL117582A (en) 2000-02-29
AU5006196A (en) 1996-10-08
NO312705B1 (no) 2002-06-24
NO973950L (no) 1997-08-27
EP0817615B1 (en) 2002-08-07
FI951316A (fi) 1996-09-22
EP0817615A2 (en) 1998-01-14
PT817615E (pt) 2002-12-31
ES2181874T3 (es) 2003-03-01
FI98343B (fi) 1997-02-28
AU694849B2 (en) 1998-07-30
ZA962271B (en) 1996-09-30
DE69622850D1 (de) 2002-09-12
FI98343C (fi) 1997-06-10
FI951316A0 (fi) 1995-03-21
CA2213747A1 (en) 1996-09-26
NO973950D0 (no) 1997-08-27

Similar Documents

Publication Publication Date Title
DK0817615T3 (da) Peroralt præparat til styret frigivelse i den nedre gastrointestinalkanal
DE69630375D1 (de) Pharmazeutische dosierungsform zur freisetzung im colon
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
DE69619668D1 (de) Pharmazeutische dosisform mit mehrfacher darmlöslicher polymerbeschichtung zur wirkstoffabgabe im kolon
ATE291901T1 (de) Neue omeprazole und (s)-omeprazole zusammensetzung
ATE340574T1 (de) Neue dosisformen von substituierten benzimidazolen und verfahren zur deren verwendung
DE69622510D1 (de) Nifedipinzubereitung mit langanhaltender Freisetzung
ATE260649T1 (de) Pharmazeutische formulierung und dosierform bestehend aus polysacchariden zur kontrollierten wirkstoff-freisetzung im dickdarm
DE69719774D1 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
DE69636724D1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
BR9806174A (pt) Péletes tendo um núcleo revestido com um antifúngico e um polìmero
NO975218L (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
CA2268868A1 (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
ATE389389T1 (de) Mehrfach beschichete pharmazeutische dosierungsform
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
WO2002024174A3 (en) Sustained release composition containing clarithromycin
ATE235232T1 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
WO1996029058B1 (en) Peroral composition for controlled release in the lower gastrointestinal tract
CA2271569A1 (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2271560A1 (en) Pharmaceutical dosage form for colonic delivery
NO992349L (no) Farmas°ytisk doseform for avlevering i tykktarmen
NO992350L (no) Farmas°ytisk doseringsform med multiple enteriske polymerbelegg for avlevering i tykktarmen